Synergistic Probiotic-AI-IoT-Blockchain System for Enhanced Antiviral Effects

A novel system integrating probiotic bacterial molecules with AI, IoT, and blockchain technologies to prevent and treat viral infections in mammals, providing real-time monitoring, optimized treatment regimens, and decentralized data storage.

The original patent disclosed antiviral methods and compositions comprising probiotic bacterial molecules. However, the patent's limitations included the lack of real-time monitoring, data analysis, and decentralized storage. The new inventive concept addresses these limitations by integrating probiotic molecules with AI, IoT, and blockchain technologies to create a more powerful and efficient system.

The synergistic system comprises a probiotic bacterial molecule-based composition, an AI-powered monitoring device, an IoT-enabled wearable device, and a blockchain-secured decentralized data storage platform. The AI module analyzes real-time data from the IoT device and blockchain network to optimize treatment regimens and predict viral outbreaks. The probiotic molecules are released in response to changes in viral loads, and the blockchain platform provides secure, decentralized data storage and real-time recommendations for treatment.

The new claims introduce the innovative combination of probiotic molecules with AI, IoT, and blockchain technologies, providing a non-obvious and novel solution for preventing and treating viral infections. The integration of these distinct technologies enables real-time monitoring, optimized treatment regimens, and decentralized data storage, which is not taught by the original patent.

Alternative embodiments may include the use of different AI algorithms, IoT device configurations, or blockchain platforms. Variations may include the integration of additional technologies, such as nanomaterial-based delivery systems or novel materials, to further enhance the system's efficiency and effectiveness.

The synergistic system has significant commercial potential in the healthcare and biotechnology industries, particularly in the development of personalized medicine and precision health. The system's ability to provide real-time monitoring and optimized treatment regimens makes it an attractive solution for hospitals, clinics, and healthcare providers.